Clinical Trial

A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)

Study acronym: RESTORE
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A Study of VV-14303 for the Treatment of Metabolic dysfunction-associated steatohepatitis (MASH)
Trial Details
NCT Number NCT07732400
Lead Sponsor Kriya Therapeutics, Inc.
Conditions Metabolic Dysfunction-associated Steatohepatitis (MASH)
Enrollment 56 participants
Start Date 2026-07
Primary Completion 2028-07 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-28